Deregulation of protein tyrosine phosphatases (PTPs) or protein tyrosine kinases (PTKs) leads to aberrant tyrosine phosphorylation, which has been implicated in the etiology of several diseases, including prostate cancer (8–10). The gene discussed is PTEN; the disease is Familial prostate cancer.